MemorialCare offers advanced, minimally invasive heart treatments like TAVR & MitraClip as alternatives to open-heart surgery ...

The U.S. Food and Drug Administration has approved Edwards Lifesciences' SAPIEN 3 platform, a transcatheter aortic valve ...

New findings from real-world experience support the shift in practice to single antiplatelet therapy after transcatheter ...

Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure used to replace damaged heart valves, ...

An innovative, minimally invasive procedure is reducing the risk faced by patients with heart valve disease and improving ...

In more serious cases, aortic valve replacement may be the best option. This can be done with traditional, open-heart surgery or with a relatively newer procedure known as transcatheter aortic ...

New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a ...

In a registry of patients who underwent transcatheter aortic valve replacement, those who had single antiplatelet therapy ...

The agency’s decision for the balloon-expandable Sapien 3 platform is based on groundbreaking results from EARLY TAVR.

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Findings from the Transfusion Requirements in Transcatheter Aortic Valve Implantation (TRITAVI) registry demonstrate that single antiplatelet therapy (SAPT) after transcatheter aortic valve ...

FDA approved the Sapien 3 transcatheter aortic valve replacement (TAVR) platform for treatment of severe aortic stenosis ...